Free shipping on all orders over $ 500

Dabigatran Etexilate

Cat. No. M3574
Dabigatran Etexilate Structure
Synonym:

BIBR-1048

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
10mM*1mL in DMSO USD 72  USD72 In stock
2mg USD 40  USD40 In stock
5mg USD 58  USD58 In stock
10mg USD 84  USD84 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

BIBR-1048 (Dabigatran) is an anticoagulant from the class of the direct thrombin inhibitors. It is being studied for various clinical indications and in many cases it offers an alternative to warfarin as the preferred orally administered blood thinner since it does not require prothrombin time monitoring while offering similar results in terms of efficacy.

Chemical Information
Molecular Weight 627.73
Formula C34H41N7O5
CAS Number 211915-06-9
Solubility (25°C) DMSO 96 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Jacqueline Halton, et al. Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial

[2] Giulio Francesco Romiti, et al. A comprehensive appraisal of dabigatran etexilate clinical evidence and applications: a 10-year-long story

[3] Leonardo R Brando, et al. Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children

[4] Jos M Ferro, et al. Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis: A Randomized Clinical Trial

[5] Hannah A Blair, et al. Dabigatran Etexilate: A Review in Nonvalvular Atrial Fibrillation

Related Thrombopoietin/Thrombin Products
Desirudin

Desirudin is a thrombin inhibitor that inhibits thrombosis and venous stasis thrombosis.Desirudin can be used in studies related to thrombocytopenia or platelet dysfunction.

TP508

TP508 is a 23-amino acid nonproteolytic thrombin peptide that represents a portion of the receptor-binding domain of thrombin molecule.

Succinyl-(Pro58, D-Glu65)-Hirudin (56-65) (sulfated)

Succinyl-(Pro58,D-Glu65)-Hirudin (56-65) (sulfated) is a hirugen-like peptide, and has high affnity for thrombin than Hirugen, with a KD < 100 nM.

Thrombin receptor peptide ligand

Thrombin receptor peptide ligand is a thrombin receptor antagonist peptide that can be used as an antithrombotic agent.

Z-Gly-Pro-Arg-4MβNA

Z-Gly-Pro-Arg-4MβNA is the cleavage of the substrate of thrombin to release free 4-methoxy-2-naphthylamine (4MβNA).

  Catalog
Abmole Inhibitor Catalog




Keywords: Dabigatran Etexilate, BIBR-1048 supplier, Thrombopoietin/Thrombin, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.